NDC 46708-223 – Darifenacin

Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC46708-223

Product details

Brand name
Darifenacin
Generic name
Darifenacin
Labeler
Alembic Pharmaceuticals Limited
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA207681
Marketed since
December 12, 2017
Listing expires
December 31, 2026
Pharmacologic class
Cholinergic Muscarinic Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Darifenacin →

Package NDC codes (4)

Package NDCDescriptionSince
46708-223-088 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46708-223-08)Dec 12, 2017
46708-223-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-223-30)Dec 12, 2017
46708-223-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-223-90)Dec 12, 2017
46708-223-911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-223-91)Dec 12, 2017

Other Darifenacin products